Clinical Trials
21 trialsNCT00898456 2023-08-18
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Active not recruiting
NCT00641030 2023-06-15
Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes
City of Hope Medical Center
Phase 1 Completed
NCT02551718 2022-06-30
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
University of Washington
Phase NA Completed
NCT00509093 2020-03-17
Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00904514 2018-10-05
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Terminated
NCT00666978 2017-11-13
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
University of Kansas Medical Center
Phase 4 Completed
NCT00450983 2017-05-24
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
Fred Hutchinson Cancer Center
Phase 2 Terminated
NCT01421875 2017-05-17
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Completed
NCT00052520 2017-03-29
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Fred Hutchinson Cancer Center
Phase 1/2 Completed
NCT01407757 2016-05-19
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
Children's Oncology Group
Completed
NCT01500499 2016-05-18
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01057095 2015-10-02
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01057199 2015-05-07
Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT00899171 2015-03-06
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia
SWOG Cancer Research Network
Completed
NCT01338974 2015-03-06
S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia
SWOG Cancer Research Network
Completed
NCT01503541 2015-03-06
S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin
SWOG Cancer Research Network
Completed
NCT01575535 2015-03-06
S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia
SWOG Cancer Research Network
Completed
NCT00723203 2014-09-09
Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
City of Hope Medical Center
Phase 2 Terminated
NCT00454480 2013-08-26
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT01421862 2013-07-10
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment
National Cancer Institute (NCI)
Unknown
NCT00899327 2009-07-08
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
National Cancer Institute (NCI)
Unknown